The store will not work correctly when cookies are disabled.
2,6-Dichloro-N-[3-(1H-tetrazol-5-yl)phenyl]-4-(trifluoromethyl)benzenesulfonamide
ID: ALA3728448
PubChem CID: 56943090
Max Phase: Preclinical
Molecular Formula: C14H8Cl2F3N5O2S
Molecular Weight: 438.22
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=S(=O)(Nc1cccc(-c2nnn[nH]2)c1)c1c(Cl)cc(C(F)(F)F)cc1Cl
Standard InChI: InChI=1S/C14H8Cl2F3N5O2S/c15-10-5-8(14(17,18)19)6-11(16)12(10)27(25,26)22-9-3-1-2-7(4-9)13-20-23-24-21-13/h1-6,22H,(H,20,21,23,24)
Standard InChI Key: FWWHLAWZTCOXKV-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
3.6384 -0.9011 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.5988 -1.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5984 -2.7004 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.6377 -2.1009 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 2.7000 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3383 -1.3500 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5988 1.5004 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-3.6378 0.9001 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6383 2.0999 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5998 3.0012 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8995 3.7516 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9027 5.2517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2032 5.9990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5007 5.2464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4977 3.7464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1971 2.9990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7958 2.9933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.1495 3.6095 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-10.1491 2.4911 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-9.3944 1.1948 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.9283 1.5120 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 1 0
2 5 1 0
5 6 2 0
6 7 1 0
7 8 1 0
7 9 2 0
9 10 1 0
10 11 1 0
10 12 2 0
12 5 1 0
9 13 1 0
13 14 2 0
13 15 2 0
13 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
21 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 438.22 | Molecular Weight (Monoisotopic): 436.9728 | AlogP: 3.99 | #Rotatable Bonds: 4 |
Polar Surface Area: 100.63 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.28 | CX Basic pKa: ┄ | CX LogP: 3.83 | CX LogD: 1.57 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.64 | Np Likeness Score: -2.23 |
References
1. (2012) New compounds, |
2. (2016) Sulfonamide compounds, |